Gillette India

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: INE322A01010
  • NSEID: GILLETTE
  • BSEID: 507815
INR
7,087.70
-66.9 (-0.94%)
BSENSE

Nov 20

BSE+NSE Vol: 23.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 8.06% vs -1.13% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is -0.22% vs -17.17% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is -0.19% vs -17.85% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 299.02% vs -69.00% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Gillette India With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
846.10
1,332.33
-486.23
-36.49%
Other Operating Income
0.00
14.17
-14.17
-100.00%
Total Operating income
846.10
1,346.50
-500.40
-37.16%
Raw Material Cost
166.11
480.68
-314.57
-65.44%
Purchase of Finished goods
210.45
454.56
-244.11
-53.70%
(Increase) / Decrease In Stocks
-8.75
-86.40
77.65
89.87%
Employee Cost
51.74
74.50
-22.76
-30.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
108.21
0.00
108.21
Other Expenses
90.98
207.18
-116.20
-56.09%
Total Expenditure (Excl Depreciation)
618.74
1,130.52
-511.78
-45.27%
Operating Profit (PBDIT) excl Other Income
227.36
215.98
11.38
5.27%
Other Income
8.37
43.52
-35.15
-80.77%
Operating Profit (PBDIT)
235.73
259.50
-23.77
-9.16%
Interest
4.07
3.52
0.55
15.63%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
231.66
255.98
-24.32
-9.50%
Depreciation
17.99
37.71
-19.72
-52.29%
Profit Before Tax
213.67
218.27
-4.60
-2.11%
Tax
54.57
55.29
-0.72
-1.30%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
159.10
162.98
-3.88
-2.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
159.10
162.98
-3.88
-2.38%
Equity Capital
32.59
31.20
1.39
4.46%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
48.82
10.45
38.37
367.18%
Diluted Earnings per share
48.83
10.45
38.38
367.27%
Operating Profit Margin (Excl OI)
26.87%
16.21%
0.00
10.66%
Gross Profit Margin
27.38%
19.21%
0.00
8.17%
PAT Margin
18.80%
12.23%
0.00
6.57%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 846.10 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 8.06% vs -1.13% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 4.35% vs 3.71% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 159.10 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -0.22% vs -17.17% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 10.76% vs 8.00% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 227.36 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -0.19% vs -17.85% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 9.43% vs 9.07% in Sep 2025

Quarterly - Interest
Interest 4.07 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 299.02% vs -69.00% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 0.00% vs 287.62% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.87%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025